Genomic and epigenetic complexity of the FOXF1 locus in 16q24.1: Implications for development and disease

Current Genomics

Volumn 16, Issue 2, 2015, Pages 107-116

  Dharmadhikari, Avinash V ^a,b   Szafranski, Przemyslaw ^a   Kalinichenko, Vladimir V ^c   Stankiewicz, Pawe ^a,b  

^a Department of Molecular and Human Genetics ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Perinatal Institute   (United States)

Author keywords

ACDMPV; Gene regulation; Genomic imprinting; Long non coding RNA; Lung development; Pulmonary vasculature

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR;

ARTICLE; CHROMOSOME ANALYSIS; COMPARATIVE MOLECULAR FIELD ANALYSIS; DISEASE COURSE; DYSPLASIA; EMBRYO DEVELOPMENT; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENOME IMPRINTING; GENOMICS; HUMAN; LUNG BLOOD VESSEL; LUNG DEVELOPMENT; NEOPLASM; NONHUMAN; POINT MUTATION;

ERINACEIDAE;

EID: 84930973409     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/1389202916666150122223252     Document Type: Article

References (111)

1. Benayoun, B.A.; Caburet, S.; Veitia, R.A. Forkhead transcription factors: key players in health and disease. Trends Genet., 2011, 27, 224-232.
2. Katoh, M.; Igarashi, M.; Fukuda, H.; Nakagama, H.; Katoh, M. Cancer genetics and genomics of human FOX family genes. Cancer Lett., 2013, 328, 198-206.
3. Hannenhalli, S.; Kaestner, K.H. The evolution of Fox genes and their role in development and disease. Nat. Rev. Genet., 2009, 10, 233-240.
4. Clark, K.L.; Halay, E.D.; Lai, E.; Burley, S. K. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature, 1993, 364, 412-420.
5. Hellqvist, M.; Mahlapuu, M.; Samuelsson, L.; Enerback, S.; Carlsson, P. Differential activation of lung-specific genes by two forkhead proteins, FREAC-1 and FREAC-2. J. Biol. Chem., 1996, 271, 4482-4490.
6. Bozyk, P.D.; Popova, A.P.; Bentley, J.K.; Goldsmith, A.M.; Linn, M.J.; Weiss, D.J.; Hershenson, M.B. Mesenchymal stromal cells from neonatal tracheal aspirates demonstrate a pattern of lungspecific gene expression. Stem Cells Dev., 2011, 20, 1995-2007.
7. Van der Heul-Nieuwenhuijsen, L.; Dits, N.F.; Jenster, G. Gene expression of forkhead transcription factors in the normal and diseased human prostate. BJU Int., 2009, 103, 1574-1580.
8. Peterson, R. S.; Lim, L.; Ye, H.; Zhou, H.; Overdier, D. G.; Costa, R. H. The winged helix transcriptional activator HFH-8 is expressed in the mesoderm of the primitive streak stage of mouse embryos and its cellular derivatives. Mech. Dev., 1997, 69, 53-69.
9. Mahlapuu, M.; Pelto-Huikko, M.; Aitola, M.; Enerbäck, S.; Carlsson, P. FREAC-1 contains a cell-type-specific transcriptional activation domain and is expressed in epithelial-mesenchymal interfaces. Dev. Biol., 1998, 202, 183-195.
10. Kalinichenko, V. V.; Zhou, Y.; Bhattacharyya, D.; Kim, W.; Shin, B.; Bambal, K.; Costa, R. H. Haploinsufficiency of the mouse Forkhead Box f1 gene causes defects in gall bladder development. J. Biol. Chem., 2002, 277, 12369-12374.
11. Kalinichenko, V. V.; Lim, L.; Stolz, D. B.; Shin, B.; Rausa, F. M.; Clark, J.; Whitsett, J. A.; Watkins, S. C.; Costa, R. H. Defects in pulmonary vasculature and perinatal lung hemorrhage in mice heterozygous null for the Forkhead Box f1 transcription factor. Dev. Biol., 2001, 235, 489-506.
12. Ren, X.; Ustiyan, V.; Pradhan, A.; Cai, Y.; Havrilak, J. A.; Bolte, C. S.; Shannon, J. M.; Kalin, T. V.; Kalinichenko, V. V. FOXF1 transcription factor is required for formation of embryonic vasculature by regulating VEGF signaling in endothelial cells. Circ. Res., 2014, 115, 709-720.
13. Kalinichenko, V. V.; Gusarova, G. A.; Shin, B.; Costa, R. H. The forkhead box F1 transcription factor is expressed in brain and head mesenchyme during mouse embryonic development. Gene Expr. Patterns, 2003, 3, 153-158.
14. Jeong, J.; Mao, J.; Tenzen, T.; Kottmann, A. H.; McMahon, A. P. Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia. Genes Dev., 2004, 18, 937-951.
15. Kalinichenko, V.V.; Lim, L.; Shin, B.; Costa, R.H. Differential expression of forkhead box transcription factors following butylated hydroxytoluene lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol., 2001, 280, L695-L704.
16. Kalinichenko, V.V.; Bhattacharyya, D.; Zhou, Y.; Gusarova, G.A.; Kim, W.; Shin, B.; Costa, R. H. Foxf1 +/-mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology, 2003, 37, 107-117.
17. Minogue, B.M.; Richardson, S.M.; Zeef, L.A.H.; Freemont, A. J.; Hoyland, J. A. Characterization of the human nucleus pulposus cell phenotype and evaluation of novel marker gene expression to define adult stem cell differentiation. Arthritis Rheum., 2010, 62, 3695-3705.
18. Mahlapuu, M.; Ormestad, M.; Enerbäck, S.; Carlsson, P. The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm. Development, 2001, 128, 155-166.
19. Mahlapuu, M.; Enerbäck, S.; Carlsson, P. Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. Development, 2001, 128, 2397-2406.
20. Astorga, J.; Carlsson, P. Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4. Development, 2007, 134, 3753-3761.
21. Madison, B. B.; McKenna, L. B.; Dolson, D.; Epstein, D. J.; Kaestner, K. H. FoxF1 and FoxL1 link hedgehog signaling and the control of epithelial proliferation in the developing stomach and intestine. J. Biol. Chem., 2009, 284, 5936-5944.
22. Li, Y.; Zhang, H.; Choi, S.C.; Litingtung, Y.; Chiang, C. Sonic hedgehog signaling regulates Gli3 processing, mesenchymal proliferation, and differentiation during mouse lung organogenesis. Dev Biol., 2004, 270, 214-231.
23. Lim, L.; Kalinichenko, V. V.; Whitsett, J. A.; Costa, R. H. Fusion of lung lobes and vessels in mouse embryos heterozygous for the forkhead box f1 targeted allele. Am. J. Physiol. Lung Cell. Mol. Physiol., 2002, 282, L1012-L1022.
24. Kalinichenko, V. V.; Gusarova, G. A.; Kim, I.-M.; Shin, B.; Yoder, H. M.; Clark, J.; Sapozhnikov, A. M.; Whitsett, J. A.; Costa, R. H. Foxf1 haploinsufficiency reduces Notch-2 signaling during mouse lung development. Am. J. Physiol. Lung Cell. Mol. Physiol., 2004, 286, L521-L530.
25. Kalin, T. V.; Meliton, L.; Meliton, A. Y.; Zhu, X.; Whitsett, J. A.; Kalinichenko, V. V. Pulmonary mastocytosis and enhanced lung inflammation in mice heterozygous null for the Foxf1 gene. Am. J. Respir. Cell Mol. Biol., 2008, 39, 390-399.
26. Kalinichenko, V. V.; Zhou, Y. A. N.; Shin, B.; Stolz, D. B.; Watkins, S. C.; Whitsett, J. A.; Costa, R. H. Wild-type levels of the mouse Forkhead Box f1 gene are essential for lung repair. Am. J. Physiol. Lung Cell Mol. Physiol., 2002, 1, 1253-1265.
27. Hoggatt, A. M.; Kim, J.-R.; Ustiyan, V.; Ren, X.; Kalin, T. V.; Kalinichenko, V. V.; Herring, B. P. The transcription factor Foxf1 binds to serum response factor and myocardin to regulate gene transcription in visceral smooth muscle cells. J. Biol. Chem., 2013, 288, 28477-28487.
28. Hoffmann, A. D.; Yang, X. H.; Burnicka-Turek, O.; Bosman, J. D.; Ren, X.; Steimle, J. D.; Vokes, S. A.; McMahon, A. P.; Kalinichenko, V. V; Moskowitz, I. P. Foxf genes integrate tbx5 and hedgehog pathways in the second heart field for cardiac septation. PLoS Genet., 2014, 10, e1004604.
29. Stankiewicz, P.; Sen, P.; Bhatt, S. S.; Storer, M.; Xia, Z.; Bejjani, B. A.; Ou, Z.; Wiszniewska, J.; Driscoll, D. J.; Maisenbacher, M. K.; Bolivar, J.; Bauer, M.; Zackai, E. H.; McDonald-McGinn, D.; Nowaczyk, M. M. J.; Murray, M.; Hustead, V.; Mascotti, K.; Schultz, R.; Hallam, L.; McRae, D.; Nicholson, A. G.; Newbury, R.; Durham-O’Donnell, J.; Knight, G.; Kini, U.; Shaikh, T. H.; Martin, V.; Tyreman, M.; Simonic, I.; Willatt, L.; Paterson, J.; Mehta, S.; Rajan, D.; Fitzgerald, T.; Gribble, S.; Prigmore, E.; Patel, A.; Shaffer, L. G.; Carter, N. P.; Cheung, S. W.; Langston, C.; Shaw-Smith, C. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am. J. Hum. Genet., 2009, 84, 780-791.
30. Bishop, N. B.; Stankiewicz, P.; Steinhorn, R. H. Alveolar capillary dysplasia. Am. J. Respir. Crit. Care Med., 2011, 184, 172-179.
31. Sen, P.; Yang, Y.; Navarro, C.; Silva, I.; Szafranski, P.; Kolodziejska, K. E.; Dharmadhikari, A. V.; Mostafa, H.; Kozakewich, H.; Kearney, D.; Cahill, J. B.; Whitt, M.; Bilic, M.; Margraf, L.; Charles, A.; Goldblatt, J.; Gibson, K.; Lantz, P. E.; Garvin, A. J.; Petty, J.; Kiblawi, Z.; Zuppan, C.; McConkie-Rosell, A.; McDonald, M. T.; Peterson-Carmichael, S. L.; Gaede, J. T.; Shivanna, B.; Schady, D.; Friedlich, P. S.; Hays, S. R.; Palafoll, I. V.; Siebers-Renelt, U.; Bohring, A.; Finn, L. S.; Siebert, J. R.; Galambos, C.; Nguyen, L.; Riley, M.; Chassaing, N.; Vigouroux, A.; Rocha, G.; Fernandes, S.; Brumbaugh, J.; Roberts, K.; Ho-Ming, L.; Lo, I. F. M.; Lam, S.; Gerychova, R.; Jezova, M.; Valaskova, I.; Fellmann, F.; Afshar, K.; Giannoni, E.; Muhlethaler, V.; Liang, J.; Beckmann, J. S.; Lioy, J.; Deshmukh, H.; Srinivasan, L.; Swarr, D. T.; Sloman, M.; Shaw-Smith, C.; van Loon, R. L.; Hagman, C.; Sznajer, Y.; Barrea, C.; Galant, C.; Detaille, T.; Wambach, J. A.; Cole, F. S.; Hamvas, A.; Prince, L. S.; Diderich, K. E. M.; Brooks, A. S.; Verdijk, R. M.; Ravindranathan, H.; Sugo, E.; Mowat, D.; Baker, M. L.; Langston, C.; Welty, S.; Stankiewicz, P. Novel FOXF1 mutations in sporadic and familial cases of alveolar capillary dysplasia with misaligned pulmonary veins imply a role for its DNA binding domain. Hum. Mutat., 2013, 34, 801-811.
32. Langston, C. Misalignment of pulmonary veins and alveolar capillary dysplasia. Paediatr. Pathol., 1991, 11, 163-170.
33. Galambos, C.; Sims-lucas, S.; Abman, S. H. Three-dimensional reconstruction identifies misaligned pulmonary veins as intrapulmonary shunt vessels in alveolar capillary dysplasia. J. Pediatr., 2014, 164, 192-195.
34. Galambos, C.; Sims-Lucas, S.; Ali, N.; Gien, J.; Dishop, M. K.; Abman, S. H. Intrapulmonary vascular shunt pathways in alveolar capillary dysplasia with misalignment of pulmonary veins. Thorax, 2015, 70, 84-85.
35. Abdallah, H.I.; Karmazin, N.; Marks, L.A. Late presentation of misalignment of lung vessels with alveolar capillary dysplasia. Crit. Care Med., 1993, 21, 628-630.
36. Shankar, V.; Haque, A.; Johnson, J.; Pietsch, J. Late presentation of alveolar capillary dysplasia in an infant. Pediatr. Crit. Care Med., 2006, 7, 177-179.
37. Szafranski, P.; Dharmadhikari, A. V.; Wambach, J. A.; Towe, C. T.; White, F. V.; Grady, R. M.; Eghtesady, P.; Cole, F. S.; Deutsch, G.; Sen, P.; Stankiewicz, P. Two deletions overlapping a distant FOXF1 enhancer unravel the role of lncRNA LINC01081 in etiology of alveolar capillary dysplasia with misalignment of pulmonary veins. Am. J. Med. Genet. A, 2014, 164A, 2013-2019.
38. MacMohan, H.E. Congenital alveolar dysplasia of the lungs. Am. J. Pathol., 1948, 24, 919-931.
39. Janney, C.G., Askin, F.B., Kuhn, C. Congenital alveolar capillary dysplasia--an unusual cause of respiratory distress in the newborn. Am. J. Clin. Pathol., 1981, 76, 722-727.
40. Sen, P., Thakur, N., Stockton, D.W., Langston, C., Bejjani, B. Expanding the phenotype of alveolar capillary dysplasia (ACD). J Pediatr., 2004, 145, 646-651.
41. Arreo Del Val, V.; Avila-Alvarez, A.; Schteffer, L. R.; Santos, F.; Deiros, L.; Del Cerro, M. J. Alveolar capillary dysplasia with misalignment of the pulmonary veins associated with aortic coarctation and intestinal malrotation. J. Perinatol., 2014, 34, 795-797.
42. Cater, G., Thibeault, D.W., Beatty, E.C., Kilbride, H.W., Huntrakoon, M. Misalignment of lung vessels and alveolar capillary dysplasia: a cause of persistent pulmonary hypertension. J. Pediatr., 1989, 114, 293-300.
43. Licht, C.; Schickendantz, S.; Sreeram, N.; Arnold, G.; Rossi, R.; Vierzig, A.; Mennicken, U.; Roth, B. Prolonged survival in alveolar capillary dysplasia syndrome. Eur. J. Pediatr., 2004, 163, 181-182.
44. Kitayama, Y.; Kamata, S.; Okuyama, H.; Usui, N.; Sawai, T.; Kobayashi, T.; Fukui, Y.; Okada, A. Nitric oxide inhalation therapy for an infant with persistent pulmonary hypertension caused by misalignment of pulmonary veins with alveolar capillary dysplasia. J. Pediatr. Surg., 1997, 32, 99-100.
45. Al-Hathlol, K.; Phillips, S.; Seshia, M.M.K.; Casiro, O.; Alvaro, R. E.; Rigatto, H. Alveolar capillary dysplasia. Report of a case of prolonged life without extracorporeal membrane oxygenation (ECMO) and review of the literature. Early Hum. Dev., 2000, 57, 85-94.
46. Alameh, J.; Bachiri, A.; Devisme, L.; Truffert, P.; Rakza, T.; Riou, Y.; Manouvrier, S.; Lequien, P.; Storme, L. Alveolar capillary dysplasia: a cause of persistent pulmonary hypertension of the newborn. Eur. J. Pediatr., 2002, 161, 262-266.
47. Plat, G., Rouquette, I., Marcoux, M.O., Bloom, M.C., Acar, P., Dulac, Y. Alveolar capillary dysplasia and persistent pulmonary hypertension of the newborn. Arch. Mal. Coeur. Vaiss., 2007, 100, 458-461.
48. Boston, U. S.; Fehr, J.; Gazit, A. Z.; Eghtesady, P. Paracorporeal lung assist device: an innovative surgical strategy for bridging to lung transplant in an infant with severe pulmonary hypertension caused by alveolar capillary dysplasia. J. Thorac. Cardiovasc. Surg., 2013, 146, e42-e43.
49. Hoganson, D. M.; Gazit, A. Z.; Boston, U. S.; Sweet, S. C.; Grady, R. M.; Huddleston, C. B.; Eghtesady, P. Paracorporeal lung assist devices as a bridge to recovery or lung transplantation in neonates and young children. J. Thorac. Cardiovasc. Surg., 2014, 147, 420-426.
50. Castilla-Fernandez, Y.; Copons-Fernández, C.; Jordan-Lucas, R.; Linde-Sillo, Á.; Valenzuela-Palafoll, I.; Ferreres Piñas, J. C.; Moreno-Galdó, A.; Castillo-Salinas, F. Alveolar capillary dysplasia with misalignment of pulmonary veins: concordance between pathological and molecular diagnosis. J. Perinatol., 2013, 33, 401-403.
51. Miranda, J.; Rocha, G.; Soares, P.; Morgado, H.; Baptista, M.J.; Azevedo, I.; Fernandes, S.; Brandão, O.; Sen, P.; Guimaraes, H. A novel mutation in FOXF1 gene associated with alveolar capillary dysplasia with misalignment of pulmonary veins, intestinal malrotation and annular pancreas. Neonatology, 2013, 103, 241-245.
52. Nguyen, L.; Riley, M. M.; Sen, P.; Galambos, C. Alveolar capillary dysplasia with misalignment of pulmonary veins with a wide spectrum of extrapulmonary manifestations. Pathol. Int., 2013, 63, 519-521.
53. Yu, S.; Shao, L.; Kilbride, H.; Zwick, D. L. Haploinsufficiencies of FOXF1 and FOXC2 genes associated with lethal alveolar capillary dysplasia and congenital heart disease. Am. J. Med. Genet. A, 2010, 152A, 1257-1262.
54. Zufferey, F.; Martinet, D.; Osterheld, M.; Niel-bütschi, F.; Besuchet, S. N.; Beckmann, J. S.; Xia, Z.; Stankiewicz, P.; Langston, C.; Fellmann, F. 16q24.1 microdeletion in a premature newborn: usefulness of array-based comparative genomic hybridization in persistent pulmonary hypertension of the newborn. Pediatr. Crit. Care Med., 2011, 12, e427-432.
55. Handrigan, G. R.; Chitayat, D.; Lionel, A. C.; Pinsk, M.; Vaags, A. K.; Marshall, C. R.; Dyack, S.; Escobar, L. F.; Fernandez, B. A.; Stegman, J. C.; Rosenfeld, J. A.; Shaffer, L. G.; Goodenberger, M.; Hodge, J. C.; Cain, J. E.; Babul-Hirji, R.; Stavropoulos, D. J.; Yiu, V.; Scherer, S. W.; Rosenblum, N. D. Deletions in 16q24.2 are associated with autism spectrum disorder, intellectual disability and congenital renal malformation. J. Med. Genet., 2013, 50, 163-173.
56. Szafranski, P.; Dharmadhikari, A. V.; Brosens, E.; Gurha, P.; Kolodziejska, K. E.; Zhishuo, O.; Dittwald, P.; Majewski, T.; Mohan, K. N.; Chen, B.; Person, R. E.; Tibboel, D.; de Klein, A.; Pinner, J.; Chopra, M.; Malcolm, G.; Peters, G.; Arbuckle, S.; Guiang, S. F.; Hustead, V. A.; Jessurun, J.; Hirsch, R.; Witte, D. P.; Maystadt, I.; Sebire, N.; Fisher, R.; Langston, C.; Sen, P.; Stankiewicz, P. Small noncoding differentially methylated copynumber variants, including lncRNA genes, cause a lethal lung developmental disorder. Genome Res., 2013, 23, 23-33.
57. Bellamkonda-Athmaram, V.; Sulman, C. G.; Basel, D. G.; Southern, J.; Konduri, G. G.; Basir, M. A. Alveolar capillary dysplasia with multiple congenital anomalies and bronchoscopic airway abnormalities. J. Perinatol., 2014, 34, 326-328.
58. Garabedian, M. J.; Wallerstein, D.; Medina, N.; Byrne, J.; Wallerstein, R. J. Prenatal Diagnosis of Cystic Hygroma related to a Deletion of 16q24.1 with Haploinsufficiency of FOXF1 and FOXC2 Genes. Case Rep. Genet., 2012, 2012, 490408.
59. Tiozzo, C.; Carraro, G.; Al Alam, D.; Baptista, S.; Danopoulos, S.; Li, A.; Lavarreda-Pearce, M.; Li, C.; De Langhe, S.; Chan, B.; Borok, Z.; Bellusci, S.; Minoo, P. Mesodermal Pten inactivation leads to alveolar capillary dysplasia-like phenotype. J. Clin. Invest., 2012, 122, 3862-3872.
60. Joza, S.; Wang, J.; Fox, E.; Hillman, V.; Ackerley, C.; Post, M. Loss of semaphorin-neuropilin-1 signaling causes dysmorphic vascularization reminiscent of alveolar capillary dysplasia. Am. J. Pathol., 2012, 181, 2003-2017.
61. Han, R. N. N.; Babaei, S.; Robb, M.; Lee, T.; Ridsdale, R.; Ackerley, C.; Post, M.; Stewart, D. J. Defective lung vascular development and fatal respiratory distress in endothelial NO synthasedeficient mice: a model of alveolar capillary dysplasia? Circ. Res., 2004, 94, 1115-1123.
62. Kim, I. M.; Zhou, Y.; Ramakrishna, S.; Hughes, D. E.; Solway, J.; Costa, R. H.; Kalinichenko, V. V. Functional characterization of evolutionarily conserved DNA regions in forkhead box f1 gene locus. J. Biol. Chem., 2005, 280, 37908-37916.
63. Szafranski, P.; Yang, Y.; Nelson, M. U.; Bizzarro, M. J.; Morotti, R. A.; Langston, C.; Stankiewicz, P. Novel FOXF1 deep intronic deletion causes lethal lung developmental disorder, alveolar capillary dysplasia with misalignment of pulmonary veins. Hum. Mutat., 2013, 34, 1467-1471.
64. Hastings, P. J.; Ira, G.; Lupski, J. R. A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet., 2009, 5, e1000327.
65. Boone, P. M.; Yuan, B.; Campbell, I. M.; Scull, J. C.; Withers, M. A.; Baggett, B. C.; Beck, C. R.; Shaw, C. J.; Stankiewicz, P.; Moretti, P.; Goodwin, W. E.; Hein, N.; Fink, J. K.; Seong, M.-W.; Seo, S. H.; Park, S. S.; Karbassi, I. D.; Batish, S. D.; Ordóñez-Ugalde, A.; Quintáns, B.; Sobrido, M.-J.; Stemmler, S.; Lupski, J. R. The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles. Am. J. Hum. Genet., 2014, 95, 143-161.
66. Kapusta, A.; Kronenberg, Z.; Lynch, V. J.; Zhuo, X.; Ramsay, L.; Bourque, G.; Yandell, M.; Feschotte, C. Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs. PLoS Genet., 2013, 9, e1003470.
67. Lee, J.; Han, K.; Meyer, T. J.; Kim, H.-S.; Batzer, M. A. Chromosomal inversions between human and chimpanzee lineages caused by retrotransposons. PLoS One, 2008, 3, e4047.
68. Startek, M.; Szafranski, P.; Gambin, T.; Campbell, I.M.; Hixson, P.; Shaw, C.A.; Stankiewicz, P.; Gambin, A. Genome-wide analyses of LINE-LINE-mediated nonallelic homologous recombination. Nucleic Acids Res., 2015, pii: gku1394.
69. Parris, T.; Nik, A. M.; Kotecha, S.; Langston, C.; Helou, K.; Platt, C.; Carlsson, P. Inversion upstream of FOXF1 in a case of lethal alveolar capillary dysplasia with misalignment of pulmonary veins. Am. J. Med. Genet. A, 2013, 161A, 764-770.
70. Khalil, A. M.; Guttman, M.; Huarte, M.; Garber, M.; Raj, A.; Rivea Morales, D.; Thomas, K.; Presser, A.; Bernstein, B. E.; van Oudenaarden, A.; Regev, A.; Lander, E. S.; Rinn, J. L. Many human large intergenic noncoding RNAs associate with chromatinmodifying complexes and affect gene expression. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 11667-11672.
71. Grote, P.; Wittler, L.; Hendrix, D.; Koch, F.; Währisch, S.; Beisaw, A.; Macura, K.; Bläss, G.; Kellis, M.; Werber, M.; Herrmann, B. G. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev. Cell, 2013, 24, 206-214.
72. Sauvageau, M.; Goff, L. A.; Lodato, S.; Bonev, B.; Groff, A. F.; Gerhardinger, C.; Sanchez-Gomez, D. B.; Hacisuleyman, E.; Li, E.; Spence, M.; Liapis, S. C.; Mallard, W.; Morse, M.; Swerdel, M. R.; D’Ecclessis, M. F.; Moore, J. C.; Lai, V.; Gong, G.; Yancopoulos, G. D.; Frendewey, D.; Kellis, M.; Hart, R. P.; Valenzuela, D. M.; Arlotta, P.; Rinn, J. L. Multiple knockout mouse models reveal lincRNAs are required for life and brain development. Elife, 2013, 2, e01749.
73. Herriges, M. J.; Swarr, D. T.; Morley, M. P.; Rathi, K. S.; Peng, T.; Stewart, K. M.; Morrisey, E. E. Long noncoding RNAs are spatially correlated with transcription factors and regulate lung development. Genes Dev., 2014, 28, 1363-1379.
74. Grote, P.; Hermann, B.G. The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis. RNA Biol., 2013, 10, 1579-1585.
75. Shaut, C.A. E.; Keene, D. R.; Sorensen, L. K.; Li, D. Y.; Stadler, H. S. HOXA13 Is essential for placental vascular patterning and labyrinth endothelial specification. PLoS Genet., 2008, 4, e1000073.
76. Vijayaraj, P.; Kroeger, C.; Reuter, U.; Hartmann, D.; Magin, T. M. Keratins regulate yolk sac hematopoiesis and vasculogenesis through reduced BMP-4 signaling. Eur. J. Cell Biol., 2010, 89, 299-306.
77. Jiang, M.; Ku, W.; Fu, J.; Offermanns, S.; Hsu, W.; Que, J. Gpr177 regulates pulmonary vasculature development. Development, 2013, 140, 3589-3594.
78. Sen, P.; Gerychova, R.; Janku, P.; Jezova, M.; Valaskova, I.; Navarro, C.; Silva, I.; Langston, C.; Welty, S.; Belmont, J.; Stankiewicz, P. A familial case of alveolar capillary dysplasia with misalignment of pulmonary veins supports paternal imprinting of FOXF1 in human. Eur. J. Hum. Genet., 2013, 21, 474-477.
79. Hassold, T.; Merrill, M.; Adkins, K.; Freeman, S.; Sherman, S. Recombination and maternal age-dependent nondisjunction: molecular studies of trisomy 16. Am. J. Hum. Genet., 1995, 57, 867-874.
80. Eggermann, T., Curtis, M., Zerres, K., Hughes H. E. Maternal uniparental disomy 16 and genetic counseling: new case and survey of published cases. Genet Couns., 2004, 15, 183-190.
81. Yong, P. J.; Marion, S. A.; Barrett, I. J.; Kalousek, D. K.; Robinson, W. P. Evidence for imprinting on chromosome 16: the effect of uniparental disomy on the outcome of mosaic trisomy 16 pregnancies. Am. J. Med. Genet., 2002, 112, 123-132.
82. Kohlhase, J., Janssen, B., Weidenauer, K., Harms, K., Bartels, I. First confirmed case with paternal uniparental disomy of chromosome 16. Am J Med Genet., 2000, 91, 190-191.
83. Lomenick, J. P.; Hubert, M. A.; Handwerger, S. Transcription factor FOXF1 regulates growth hormone variant gene expression. Am. J. Physiol. Endocrinol. Metab., 2006, 291, E947-E951.
84. Malin, D.; Kim, I.-M.; Boetticher, E.; Kalin, T. V.; Ramakrishna, S.; Meliton, L.; Ustiyan, V.; Zhu, X.; Kalinichenko, V. V. Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression. Mol. Cell. Biol., 2007, 27, 2486-2498.
85. Sen, P.; Dharmadhikari, A. V.; Majewski, T.; Mohammad, M. A.; Kalin, T. V.; Zabielska, J.; Ren, X.; Bray, M.; Brown, H. M.; Welty, S.; Thevananther, S.; Langston, C.; Szafranski, P.; Justice, M. J.; Kalinichenko, V. V.; Gambin, A.; Belmont, J.; Stankiewicz, P. Comparative analyses of lung transcriptomes in patients with alveolar capillary dysplasia with misalignment of pulmonary veins and in foxf1 heterozygous knockout mice. PLoS One, 2014, 9, e94390.
86. Coon, D. R.; Roberts, D. J.; Loscertales, M.; Kradin, R. Differential epithelial expression of SHH and FOXF1 in usual and nonspecific interstitial pneumonia. Exp. Mol. Pathol., 2006, 80, 119-123.
87. Melboucy-Belkhir, S.; Pradère, P.; Tadbiri, S.; Habib, S.; Bacrot, A.; Brayer, S.; Mari, B.; Besnard, V.; Mailleux, A. A.; Guenther, A.; Castier, Y.; Mal, H.; Crestani, B.; Plantier, L. Forkhead Box F1 represses cell growth and inhibits COL1 and ARPC2 expression in lung fibroblasts in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol., 2014, 307, L838-847.
88. Walker, N.; Badri, L.; Wettlaufer, S.; Flint, A.; Sajjan, U.; Krebsbach, P. H.; Keshamouni, V. G.; Peters-Golden, M.; Lama, V. N. Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. Am. J. Pathol., 2011, 178, 2461-2469.
89. Lo, P.-K.; Lee, J. S.; Liang, X.; Han, L.; Mori, T.; Fackler, M. J.; Sadik, H.; Argani, P.; Pandita, T. K.; Sukumar, S. Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer. Cancer Res., 2010, 70, 6047-6058.
90. Mitchell, S. M.; Ross, J. P.; Drew, H. R.; Ho, T.; Brown, G. S.; Saunders, N. F. W.; Duesing, K. R.; Buckley, M. J.; Dunne, R.; Beetson, I.; Rand, K. N.; McEvoy, A.; Thomas, M. L.; Baker, R. T.; Wattchow, D. A.; Young, G. P.; Lockett, T. J.; Pedersen, S. K.; Lapointe, L. C.; Molloy, P. L. A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer, 2014, 14, 54.
91. Pálmer, H. G.; Sánchez-carbayo, M.; Ordóñez-morán, P.; Sa, M.; Ordo, P.; Cordo, C. Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res., 2003, 63, 7799-7806.
92. Wong, N.; Chan, K. Y.; Macgregor, P. F.; Lai, P. B.; Squire, J. A.; Beheshti, B.; Albert, M.; Leung, T. W. Transcriptional profiling identifies gene expression changes associated with IFN-alpha tolerance in hepatitis C-related hepatocellular carcinoma cells. Clin. Cancer Res., 2005, 11, 1319-1326.
93. Tamura, M.; Sasaki, Y.; Koyama, R.; Takeda, K.; Idogawa, M.; Tokino, T. Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness. Oncogene, 2013, 33, 4837-4846.
94. Watson, J. E. V.; Doggett, N. A.; Albertson, D. G.; Andaya, A.; Chinnaiyan, A.; van Dekken, H.; Ginzinger, D.; Haqq, C.; James, K.; Kamkar, S.; Kowbel, D.; Pinkel, D.; Schmitt, L.; Simko, J. P.; Volik, S.; Weinberg, V. K.; Paris, P. L.; Collins, C. Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer. Oncogene, 2004, 23, 3487-3494.
95. Wei, H.J.; Nickoloff, J. A.; Chen, W.; Liu, H.; Chang, Y.; Yang, P.; Wu, C.; Williams, D. F.; Gelovani, G.; Deng, W. FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells. Oncotarget, 2014, 5, 9514-9529.
96. Nilsson, J.; Helou, K.; Kovács, A.; Bendahl, P.-O.; Bjursell, G.; Fernö, M.; Carlsson, P.; Kannius-Janson, M. Nuclear Janusactivated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. Cancer Res., 2010, 70, 2020-2029.
97. Saito, R.A.; Micke, P.; Paulsson, J.; Augsten, M.; Peña, C.; Jönsson, P.; Botling, J.; Edlund, K.; Johansson, L.; Carlsson, P.; Jirström, K.; Miyazono, K.; Ostman, A. Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. Cancer Res., 2010, 70, 2644-2654.
98. Katoh, Y.; Katoh, M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr. Mol. Med., 2009, 9, 873-886.
99. Wendling, D. S.; Lück, C.; von Schweinitz, D.; Kappler, R. Characteristic overexpression of the forkhead box transcription factor Foxf1 in Patched-associated tumors. Int. J. Mol. Med., 2008, 22, 787-792.
100. Armeanu-Ebinger, S.; Bonin, M.; Häbig, K.; Poremba, C.; Koscielniak, E.; Godzinski, J.; Warmann, S. W.; Fuchs, J.; Seitz, G. Differential expression of invasion promoting genes in childhood rhabdomyosarcoma. Int. J. Oncol., 2011, 38, 993-1000.
101. Gialmanidis, I. P.; Bravou, V.; Petrou, I.; Kourea, H.; Mathioudakis, A.; Lilis, I.; Papadaki, H. Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer. Lung, 2013, 191, 511-521.
102. Su, Z.; Gay, L. J.; Strange, A.; Palles, C.; Band, G.; Whiteman, D. C.; Lescai, F.; Langford, C.; Nanji, M.; Edkins, S.; van der Winkel, A.; Levine, D.; Sasieni, P.; Bellenguez, C.; Howarth, K.; Freeman, C.; Trudgill, N.; Tucker, A. T.; Pirinen, M.; Peppelenbosch, M. P.; van der Laan, L. J. W.; Kuipers, E. J.; Drenth, J. P. H.; Peters, W. H.; Reynolds, J. V.; Kelleher, D. P.; McManus, R.; Grabsch, H.; Prenen, H.; Bisschops, R.; Krishnadath, K.; Siersema, P. D.; van Baal, J. W. P. M.; Middleton, M.; Petty, R.; Gillies, R.; Burch, N.; Bhandari, P.; Paterson, S.; Edwards, C.; Penman, I.; Vaidya, K.; Ang, Y.; Murray, I.; Patel, P.; Ye, W.; Mullins, P.; Wu, A. H.; Bird, N. C.; Dallal, H.; Shaheen, N. J.; Murray, L. J.; Koss, K.; Bernstein, L.; Romero, Y.; Hardie, L. J.; Zhang, R.; Winter, H.; Corley, D. A.; Panter, S.; Risch, H. A.; Reid, B. J.; Sargeant, I.; Gammon, M. D.; Smart, H.; Dhar, A.; McMurtry, H.; Ali, H.; Liu, G.; Casson, A. G.; Chow, W.-H.; Rutter, M.; Tawil, A.; Morris, D.; Nwokolo, C.; Isaacs, P.; Rodgers, C.; Ragunath, K.; MacDonald, C.; Haigh, C.; Monk, D.; Davies, G.; Wajed, S.; Johnston, D.; Gibbons, M.; Cullen, S.; Church, N.; Langley, R.; Griffin, M.; Alderson, D.; Deloukas, P.; Hunt, S. E.; Gray, E.; Dronov, S.; Potter, S. C.; Tashakkori-Ghanbaria, A.; Anderson, M.; Brooks, C.; Blackwell, J. M.; Bramon, E.; Brown, M. a; Casas, J. P.; Corvin, A.; Duncanson, A.; Markus, H. S.; Mathew, C. G.; Palmer, C. N. A.; Plomin, R.; Rautanen, A.; Sawcer, S. J.; Trembath, R. C.; Viswanathan, A. C.; Wood, N.; Trynka, G.; Wijmenga, C.; Cazier, J.-B.; Atherfold, P.; Nicholson, A. M.; Gellatly, N. L.; Glancy, D.; Cooper, S. C.; Cunningham, D.; Lind, T.; Hapeshi, J.; Ferry, D.; Rathbone, B.; Brown, J.; Love, S.; Attwood, S.; MacGregor, S.; Watson, P.; Sanders, S.; Ek, W.; Harrison, R. F.; Moayyedi, P.; de Caestecker, J.; Barr, H.; Stupka, E.; Vaughan, T. L.; Peltonen, L.; Spencer, C. C. A.; Tomlinson, I.; Donnelly, P.; Jankowski, J. A. Z. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus. Nat. Genet., 2012, 44, 1131-1136.
103. Dura, P.; van Veen, E. M.; Salomon, J.; te Morsche, R. H. M.; Roelofs, H. M. J.; Kristinsson, J. O.; Wobbes, T.; Witteman, B. J. M.; Tan, A. C. I. T. L.; Drenth, J. P. H.; Peters, Wilbert, H. M. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk. Int. J. Cancer, 2013, 133, 1751-1755.
104. Rafiq, S.; Khan, S.; Tapper, W.; Collins, A.; Upstill-Goddard, R.; Gerty, S.; Blomqvist, C.; Aittomaki, K.; Couch, F.J.; Liu, J.; Nevanlinna, H.; Eccles, D. A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis. PLoS One, 2014, 9, e101488.
105. Levine, D. M.; Ek, W. E.; Zhang, R.; Liu, X.; Onstad, L.; Sather, C.; Lao-Sirieix, P.; Gammon, M. D.; Corley, D. A.; Shaheen, N. J.; Bird, N. C.; Hardie, L. J.; Murray, L. J.; Reid, B. J.; Chow, W.-H.; Risch, H. A.; Nyrén, O.; Ye, W.; Liu, G.; Romero, Y.; Bernstein, L.; Wu, A. H.; Casson, A. G.; Chanock, S. J.; Harrington, P.; Caldas, I.; Debiram-Beecham, I.; Caldas, C.; Hayward, N. K.; Pharoah, P. D.; Fitzgerald, R. C.; Macgregor, S.; Whiteman, D. C.; Vaughan, T. L. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett’s esophagus. Nat. Genet., 2013, 45, 1487-1493.
106. Kucharczyk, M.; Kochański, A.; Jezela-Stanek, A.; Kugaudo, M.; Sielska-Rotblum, D.; Gutkowska, A.; Krajewska-Walasek, M. The first case of a patient with de novo partial distal 16q tetrasomy and a data’s review. Am. J. Med. Genet. A, 2014, 164, 2541-2550.
107. Dharmadhikari, A.V.; Gambin, T.; Szafranski, P.; Cao, W.; Probst, F.J.; Jin, W.; Fang, P.; Gogolewski, K.; Gambin, A.; George-Abraham, J.K.; Golla, S.; Boidein, F.; Duban-Bedu, B.; Delobel, B; Andrieux, J.; Becker, K.; Holinski-Feder, E.; Cheung, S.; Stankiewicz, P. Molecular and clinical analyses of 16q24.1 duplications involving FOXF1 identify an evolutionarily unstable large minisatellite. BMC Med Genet., 2014, 15, 128.
108. Leuer, M., Oldenburg, J., Lavergne, J.M., Ludwig, M., Fregin, A., Eigel, A., Ljung, R., Goodeve, A., Peake, I., Olek, K. Somatic mosaicism in hemophilia A: a fairly common event. Am. J. Hum. Genet., 2001, 69, 75-87.
109. Helderman-van den Enden, A.T.; de Jong, R., den Dunnen, J.T., Houwing-Duistermaat, J.J., Kneppers, A.L., Ginjaar, H.B., Breuning, M.H., Bakker, E. Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy. Clin. Genet., 2009, 75, 465-472.
110. Campbell, I.M.; Yuan, B.; Robberecht, C.; Pfundt, R.; Szafranski, P.; McEntagart, M.E.; Nagamani, S.C.; Erez, A.; Bartnik, M.; Wiśniowiecka-Kowalnik, B.; Plunkett, K.S.; Pursley, A.N.; Kang, S.H.; Bi, W.; Lalani, S.R.; Bacino, C.A.; Vast, M.; Marks, K.; Patton, M.; Olofsson, P.; Patel, A.; Veltman, J.A.; Cheung, S.W.; Shaw, C.A.; Vissers, L.E.; Vermeesch, J.R.; Lupski, J.R.; Stankiewicz, P. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am. J. Hum. Genet., 2014, 95, 173-182.
111. Campbell, I.M.; Stewart, J.R.; James, R.A.; Lupski, J.R.; Stankiewicz, P.; Olofsson, P.; Shaw, C.A. Parent of origin, mosaicism, and recurrence risk: probabilistic modeling explains the broken symmetry of transmission genetics. Am. J. Hum. Genet., 2014, 95, 345-359.